Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The aim of this study is to compare CHOP versus CEOP-induced cardiotoxicity in patients with aggressive B-cell lymphoma. The hypothesis is epirubicin is associated with less cardiotoxicity without compromising the efficacy.
Epistemonikos ID: 523f36a1fc3414e6c31e0eb4ad3ec439ab2e7957
First added on: May 05, 2024